Prevention of BSI and VAP Measuring Change in Outcomes Part II
description
Transcript of Prevention of BSI and VAP Measuring Change in Outcomes Part II
![Page 1: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/1.jpg)
Prevention of BSI and VAPMeasuring Change in Outcomes
Part IITed Speroff, PhD
![Page 2: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/2.jpg)
Using NNIS Rate Measures is a Problem for QI
• NNIS Rates are used in surveillance to detect outbreaks – a rise in rates!– Also, easier to make site comparisons– And easier to pool data into single rate
• However, the goal of QI is to decrease the rate.• The area you have to work with is between the
mean rate and 0.• It is very hard to show improvement using rate
as your measure.
![Page 3: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/3.jpg)
Control Chart for NNIS Rate
Central Line is Mean =5.0/1000 days
UCL
LCL = -1.7
When the lower (LCL) control limit is below zero, you have to collect data for a much longer period of time to move the LCL above zero.
X-axis is Time Scale: days, weeks months
To show improvement the rate will be in this area.
![Page 4: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/4.jpg)
Solution: g Chart
• Change your Measure• The number of days between events
– Date #2 minus Date #1
• Goal: to increase the number of days between events• There is no upper boundary• As the NNIS rate decreases, the number of days
between events increases.• G chart is sensitive for detecting a decrease in NNIS rate• Don’t need to know the census (denominator), just the
dates of infections. Thus, not dependent on the number of line-days or vent-days of your ICU.
![Page 5: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/5.jpg)
ExampleQual Saf Health Care 2005;14:295-302
0
50
100
150
200
250
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45
Infection Number
Da
ys
Be
twe
en
Infe
cti
on
s
UCL = 109 days
Mean = 27 days
Intervention
2000 2001 2002 2003-2004 Year:
Figure 3. Days between CVC-related bloodstream infections (G Chart)January 2000 – October 2004
The G chart monitors time between events. The goal is to increase time between infections, hence higher points indicate better performance. As the BSI rate decreases, there are fewer data points per year—this is reflected in shorter calendar-year bars along the top. The baseline period is from January 2000 through October 2002 (infections 1 – 39). The intervention period is from November 2002 through October 2004 (infections 40-45). During the baseline period, the number of days between infections was consistently below the upper control limit (UCL), suggesting the variation in time between infections was random and inherent to the process of CVC care. During the post-intervention period, the number of days between infections was frequently above the UCL, suggesting the intervention had introduced non-random improvements into the process of care.
![Page 6: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/6.jpg)
Additional Rules for Control ChartsStatistical Significance
• Single point above the UCL
• 2 of 3 consecutive points between 2 and 3 sigma
• 6 consecutive points in an upward trend
• 9 consecutive points above or below the central line (mean)
![Page 7: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/7.jpg)
Excel File Template:Tabs – C-Line BSI & VAP
![Page 8: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/8.jpg)
Reminder:Change Name of File and
Save Often
![Page 9: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/9.jpg)
First Entry: MM/DD/YYYYDate of first BSI in your ICU
![Page 10: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/10.jpg)
Continue with Second EntryNote: Days between Events takes
at least two entries
![Page 11: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/11.jpg)
Completion of Second Entrystarts the Control Chart
![Page 12: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/12.jpg)
Baseline Data EntryFrom Row 20 to 42
![Page 13: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/13.jpg)
Set Baseline: Move Cursor to Cell F20
Edit from B45 to B42
![Page 14: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/14.jpg)
Edit of Chart Title and Data EntryComplete
![Page 15: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/15.jpg)
![Page 16: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/16.jpg)
VAP G Chart
![Page 17: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/17.jpg)
VAP NNIS Worksheet
![Page 18: Prevention of BSI and VAP Measuring Change in Outcomes Part II](https://reader035.fdocuments.net/reader035/viewer/2022062322/56814749550346895db48853/html5/thumbnails/18.jpg)
End of Part II
Questions and Commentsso far?
Continue Part III